Sun Pharmaceutical Industries Ltd. rose ~1.77% in trading, outperforming rival companies in the pharma sector. While the broader sensex saw muted gains, Sun Pharma’s volume exceeded its 50-day average, indicating growing investor interest. Despite the uptick, the stock remains around 16% below its 52-week high. The strong showing reflects confidence in pharma, given easing regulatory concerns and potential tailwinds from global demand for drug supplies.